Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (2127)	1/15/2008 10:45:00 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

HLCS run this month is just as strong as the one it had in Oct in spite of the lack of the January Effect & poor cooperation from the general market. It is making an all time H, trading above its Oct 12 H, while volume has remained below the Oct range. bigcharts.marketwatch.com It announced last week a formal collaboration with Dr. Victor Ambros to apply the quantitative power of its True Single Molecule Sequencing to develop a single assay to characterize known species of miRNA as well as discover new non-coding RNAs. Dr. Ambros discovered the existence of miRNA’s by finding the Lin-4 during a study of developmental timing in roundworm, Caenorhabditis elegans. His research on microRNA function and gene regulation during development,is focusing on understanding the genetic and molecular mechanisms that control cell division, differentiation and morphogenesis in animals. Although it is expected that HLCS will have larger losses for the next Yr or two, it helps that the insiders control >60% <g> The Short Ratio is < 5x its ADV & the float is < 7M bigcharts.marketwatch.com Bernard